Overview

  • Product name
    CTAP
  • Description
    Potent, selective μ opioid antagonist
  • Biological description
    Potent and selective μ opioid receptor antagonist (1200-fold more selective vs. δ receptor). Blood-brain barrier permeable and active in vivo. Antagonizes antinociceptive effect.

Properties

References

This product has been referenced in:
  • Steinmiller CL & Young AM Pharmacological selectivity of CTAP in a warm water tail-withdrawal antinociception assay in rats. Psychopharmacology (Berl) 195:497-507 (2008). Read more (PubMed: 17882404) »
  • Sterious SN & Walker EA Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay. J Pharmacol Exp Ther 304:301-9 (2003). Read more (PubMed: 12490605) »
  • Abbruscato TJ  et al. Blood-brain barrier permeability and bioavailability of a highly potent and mu-selective opioid receptor antagonist, CTAP: comparison with morphine. J Pharmacol Exp Ther 280:402-9 (1997). Read more (PubMed: 8996221) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab120680.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up